✦ LIBER ✦

Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles

✍ Scribed by Georg Griesinger; E.M. Kolibianakis; E.G. Papanikolaou; K. Diedrich; A. Van Steirteghem; P. Devroey; Helle Ejdrup Bredkjaer; Peter Humaidan

Book ID: 116470541
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 93 KB
Volume: 88
Category: Article
ISSN: 1556-5653
DOI: 10.1016/j.fertnstert.2006.12.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Triggering with human chorionic gonadotr

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study

✍ Daniel Bodri; Juan José Guillén; Anna Galindo; Daniel Mataró; Aïda Pujol; Oriol 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Two types of different formulation of go

Two types of different formulation of gonadotropin-releasing hormone agonist or human chorionic gonadotropin recombinant (r-hCG) for final oocyte maturation in donor cycles

✍ A.L. Torno; L. Ferle; V.E. Cañada; E.A. Salama 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Dual trigger of oocyte maturation with g

Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders

✍ Daniel Griffin; Claudio Benadiva; Nicole Kummer; Tara Budinetz; John Nulsen; Law 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Gonadotropin-releasing hormone agonist c

Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization

✍ Bruce S. Shapiro; Said T. Daneshmand; Forest C. Garner; Martha Aguirre; Shyni Th 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Lower serum levels of inhibin A and pro-

Lower serum levels of inhibin A and pro-αC during the luteal phase after triggering oocyte maturation with gonadotropin releasing hormone (GnRH) agonist in comparison to human chorionic gonadotropin (hCG): possible relevance for the prevention of ovarian hyperstimulation (OHSS)

✍ Ori Nevo; Talia Eldar-Geva; Shahar Kol; Joseph Itskovitz-Eldor 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 22 KB

Prevention of Ovarian Hyperstimulation S

Prevention of Ovarian Hyperstimulation Syndrome (OHSS) With the Use of Gonadotropin Releasing Hormone (GnRH) Agonist to Trigger Final Oocyte Maturation After Cotreatment With GnRH Antagonist in Patients With Polycystic Ovarian Syndrome (PCOS) or Previous High Response Undergoing IVF Treatment—A Prospective Randomized Clinical Trial

✍ L. Engmann; A. Diluigi; D. Schmidt; J. Nulsen; D. Maier; C. Benadiva 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 91 KB